Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in Medicine, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 42 Mendeley

Summary News X Reddit Dimensions citations

So far, Altmetric has seen 1 news story.

Responding to Resistance in Lung Cancer

OncLive, 25 Oct 2023

Phillip Dennis Vice President, Lung Cancer and CEACAM Global Project Head Sanofi Sponsored Content by SANOFI Lung cancer is one…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.